{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T10:43:23Z","timestamp":1769683403534,"version":"3.49.0"},"reference-count":85,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2006,7,10]],"date-time":"2006-07-10T00:00:00Z","timestamp":1152489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2006,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Angiogenesis is a physiologic process of new blood vessels formation mediated by various cytokines called angiogenic and angiostatic factors. Although its potential pathophysiologic role in solid tumors has been extensively studied for more than 3 decades, enhancement of angiogenesis in chronic lymphocytic leukemia (CLL) and other malignant hematological disorders has been recognized more recently. An increased level of angiogenesis has been documented by various experimental methods both in bone marrow and lymph nodes of patients with CLL. Although the role of angiogenesis in the pathophysiology of this disease remains to be fully elucidated, experimental data suggest that several angiogenic factors play a role in the disease progression. Biologic markers of angiogenesis were also shown to be of prognostic relevance in CLL. The current findings provide the rationale for investigating antiangiogenic agents in CLL. In the current review angiogenesis in CLL is discussed and its potential diagnostic and therapeutic applications. Cancer 2006. \u00a9 2006 American Cancer Society.<\/jats:p>","DOI":"10.1002\/cncr.22086","type":"journal-article","created":{"date-parts":[[2006,7,10]],"date-time":"2006-07-10T14:01:56Z","timestamp":1152540116000},"page":"925-934","source":"Crossref","is-referenced-by-count":42,"title":["Role of angiogenesis in chronic lymphocytic leukemia"],"prefix":"10.1002","volume":"107","author":[{"given":"Tomislav","family":"Letilovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radovan","family":"Vrhovac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srdan","family":"Verstovsek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branimir","family":"Jaksic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Ferrajoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,10]]},"reference":[{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512283332608"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197111182852108"},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190400003267"},{"key":"e_1_2_11_6_2","first-page":"815","article-title":"Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia","volume":"150","author":"Perez\u2010Atayde AR","year":"1997","journal-title":"Am J Pathol."},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.8.2637"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.11.4131"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1242\/dev.102.3.471"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0093-7754(01)90287-8"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/hq0701.093685"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4838(99)00279-4"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81010-7"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1997.d01-606.x"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199101033240101"},{"key":"e_1_2_11_16_2","first-page":"9","article-title":"Intratumor vessel density as a prognostic factor in cancer","volume":"147","author":"Weidner N","year":"1995","journal-title":"Am J Pathol."},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(96)00149-5"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.26.14608"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0901-987"},{"key":"e_1_2_11_20_2","first-page":"179","article-title":"Tumor angiogenesis targeting using imaging agents","volume":"45","author":"Weber WA","year":"2001","journal-title":"Q J Nucl Med."},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2257.1991.tb00297.x"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.368"},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.158"},{"key":"e_1_2_11_24_2","first-page":"3121","article-title":"Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma","volume":"63","author":"Poon RT","year":"2003","journal-title":"Cancer Res."},{"key":"e_1_2_11_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2004.027912"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2408340"},{"key":"e_1_2_11_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3658"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1768"},{"key":"e_1_2_11_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2005.00549.x"},{"key":"e_1_2_11_30_2","first-page":"4341","article-title":"Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma","volume":"61","author":"Monestiroli S","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_11_31_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.6.2240"},{"key":"e_1_2_11_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2004.07.012"},{"key":"e_1_2_11_33_2","first-page":"827","article-title":"Clinical tumor cell distribution pattern is a prognostically relevant parameter in patients with B\u2010cell chronic lymphocytic leukemia","volume":"86","author":"Jaksic O","year":"2001","journal-title":"Haematologica."},{"key":"e_1_2_11_34_2","doi-asserted-by":"publisher","DOI":"10.1159\/000046611"},{"key":"e_1_2_11_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(00)00508-7"},{"key":"e_1_2_11_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402012"},{"key":"e_1_2_11_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403667"},{"key":"e_1_2_11_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403631"},{"key":"e_1_2_11_39_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.6-suppl_5-4"},{"key":"e_1_2_11_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02731.x"},{"key":"e_1_2_11_41_2","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood.V95.8.2630","article-title":"Vascular endothelial growth factor and interleukin 6 in paracrine tumor\u2010stromal cell interactions in multiple myeloma","volume":"95","author":"Dankbar B","year":"2000","journal-title":"Blood."},{"key":"e_1_2_11_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401825"},{"key":"e_1_2_11_43_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-10-4054"},{"key":"e_1_2_11_44_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3890"},{"key":"e_1_2_11_45_2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4049\/jimmunol.160.1.395","article-title":"Human CD38 (ADP\u2010ribosyl cyclase) is a counter receptor of CD31, an Ig superfamily member","volume":"160","author":"Deaglio S","year":"1998","journal-title":"J Immunol."},{"key":"e_1_2_11_46_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0989"},{"key":"e_1_2_11_47_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.8.2529"},{"key":"e_1_2_11_48_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0084"},{"key":"e_1_2_11_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2003.08.001"},{"key":"e_1_2_11_50_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.9.3181.h8003181_3181_3187"},{"key":"e_1_2_11_51_2","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1182\/blood.V85.7.1978.bloodjournal8571978","article-title":"Increased intracellular and plasma levels of basic fibroblast growth factor in B\u2010cell chronic lymphocytic leukemia","volume":"85","author":"Duensing S","year":"1995","journal-title":"Blood."},{"key":"e_1_2_11_52_2","doi-asserted-by":"publisher","DOI":"10.1080\/0962935031000134888"},{"key":"e_1_2_11_53_2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V87.3.1056.bloodjournal8731056","article-title":"Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic leukemia and is associated with resistance to fludarabine","volume":"87","author":"Menzel T","year":"1996","journal-title":"Blood."},{"key":"e_1_2_11_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400556"},{"key":"e_1_2_11_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402467"},{"key":"e_1_2_11_56_2","first-page":"145","article-title":"Cladribine decreases the level of angiogenic factors in patients with chronic lymphocytic leukemia","volume":"49","author":"Gora\u2010Tybor J","year":"2002","journal-title":"Neoplasma."},{"key":"e_1_2_11_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600022"},{"key":"e_1_2_11_58_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.2.768.014k23_768_770"},{"key":"e_1_2_11_59_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00341a030"},{"key":"e_1_2_11_60_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.6.2232"},{"key":"e_1_2_11_61_2","first-page":"149","article-title":"Angiogenic and angiostatic factors in the molecular control of angiogenesis","volume":"47","author":"Distler JW","year":"2003","journal-title":"Q J Nucl Med."},{"key":"e_1_2_11_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2004.00269.x"},{"key":"e_1_2_11_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(03)00256-X"},{"key":"e_1_2_11_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2003.10.014"},{"key":"e_1_2_11_65_2","first-page":"795","article-title":"High levels of vascular endothelial growth factor receptor\u20102 correlate with shortened survival in chronic lymphocytic leukemia","volume":"7","author":"Ferrajoli A","year":"2001","journal-title":"Clin Cancer Res."},{"key":"e_1_2_11_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(00)00139-9"},{"key":"e_1_2_11_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402472"},{"key":"e_1_2_11_68_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04877.x"},{"key":"e_1_2_11_69_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2003.00064.x"},{"key":"e_1_2_11_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/37126"},{"key":"e_1_2_11_71_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.27.599"},{"key":"e_1_2_11_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04046-0"},{"key":"e_1_2_11_73_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10416"},{"key":"e_1_2_11_74_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0669"},{"key":"e_1_2_11_75_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0669"},{"key":"e_1_2_11_76_2","first-page":"135a","article-title":"Results of phase II study of lenalidomide (L) (Revlimid\u00ae) in patients with relapsed or refractory chronic lymphocytic leukemia (CLL)","volume":"106","author":"Chanan\u2010Khan AA","year":"2005","journal-title":"Blood."},{"key":"e_1_2_11_77_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203105"},{"key":"e_1_2_11_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403469"},{"key":"e_1_2_11_79_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.cad.0000127332.06439.47"},{"key":"e_1_2_11_80_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02895.x"},{"key":"e_1_2_11_81_2","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/blood.V92.10.3804","article-title":"Flavopiridol induces apoptosis in chronic lymphocitic leukemia via activation of caspase\u20103 without evidence of bcl\u20102 modulation or dependence on functional p\u201053","volume":"92","author":"Byrd JC","year":"1998","journal-title":"Blood."},{"key":"e_1_2_11_82_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2276"},{"key":"e_1_2_11_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2005.03.010"},{"key":"e_1_2_11_84_2","first-page":"278a","article-title":"Flavopiridol, fludarabine and rituximab is a highly active regimen in indolent B\u2010cell lymphoproliferative disorders including mantle cell lymphoma","volume":"106","author":"Lin TS","year":"2005","journal-title":"Blood."},{"key":"e_1_2_11_85_2","doi-asserted-by":"crossref","first-page":"211a","DOI":"10.1182\/blood.V106.11.712.712","article-title":"Evaluation of the prognostic implications of pro\u2010 and anti\u2010angiogenic cytokines in 311 patients with untreated chronic lymphocytic leukemia","volume":"106","author":"Shanafelt TD","year":"2005","journal-title":"Blood."},{"key":"e_1_2_11_86_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.moh.0000168521.76120.7b"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.22086","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.22086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:23:23Z","timestamp":1760268203000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.22086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,10]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["10.1002\/cncr.22086"],"URL":"https:\/\/doi.org\/10.1002\/cncr.22086","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,10]]}}}